The global skin booster market size was exhibited at USD 1.9 billion in 2022 and is projected to hit around USD 4.8 billion by 2032, growing at a CAGR of 9.7% during the forecast period 2023 to 2032.
Key Pointers:
Skin Boosters Market Report Scope
Report Coverage | Details |
Market Size in 2023 | USD 2.08 Billion |
Market Size by 2032 | USD 4.8 Billion |
Growth Rate From 2023 to 2032 | CAGR of 9.7% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segments Covered | Type, Gender, End-use |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
Key Companies Profiled | Allergan Plc; Gladerma; Merz Aesthetics; Bloomage Biotechnology; Teoxanne; Filorga; Professional Derma SA; IBSA - InstituteBiochemical SA (IBSA Derma) |
The desire to look youthful among the millennials and rising consumption of aesthetic procedures by both men and women, especially from the emerging economies are majorly estimated to drive the market growth. However, the advent of the COVID-19 pandemic has hugely affected the overall non-invasive aesthetic industry. Several dermatology clinics have witnessed a boost in the number of future appointments and consultations for different skin treatments, and this is expected to boost the market growth
Skin boosters are micro-injections of hyaluronic acid, vitamins, and minerals that are injected into the epidermis to revitalize, hydrate, and rejuvenate the skin for a natural glow. Skin Boosters do not contour or shape the facial structure but can be used on the face, neck, hands, and décolletage. Skin booster treatments restore hydro balance in the skin through the replenishment of hyaluronic acid, resulting in more effective retention of moisture and bringing firmness to the skin.
The Mesotherapy type segment in the U.S is expected to grow at highest compound annual growth rate of 9.7% from 2023 to 2030. The popular trend of achieving glass skin with a porcelain- like, light texture that is devoid of impurities and spots has boosted the adoption of skin boosters. Cosmeceutical injections like Skin boosters are designed to boost collagen production and amplify the skin's natural ability to self-repair. This can be attributed to factors such as technological advancements, relatively higher disposable income, and the availability of several aesthetic professionals in the country. Furthermore, the U.S. is among the most favored market for aesthetic companies for new product launches. For instance, in January 2017, Allergan plc launched Juvéderm Volite, an injectable product that uses the patented Vycross technology is specifically designed to improve skin quality and last up to nine months with just one treatment session.
The increasing geriatric population in the U.S and Canada is expected to further boost the market growth. Signs of aging dull skin texture, lack of skin elasticity, firmness, and dark spots start appearing between 25 and 30 years of age and become more prominent from 30 to 65 years of age. These above-mentioned factors are expected to propel market growth.
Despite the COVID-19 pandemic negatively impacting several industries, the skin booster procedures has witnessed an increase in procedures. Due to Covid-19, the work from home concept is readily adopted. A new trend in the esthetics industry is the growing pressure of looking more appealing on virtual platforms, such as Zoom, during meetings and conferences. According to WKYC Studio, the desire to look perfect and confident on camera is a major cause of an increase in procedure booking observed by esthetic professionals in 2020. Aesthetic & cosmetic doctors across the globe, including the U.S., U.K., Australia, South Korea, and Japan have reported an increase in injectable procedure appointments which also includes skin booster treatments after the pandemic and this is expected to further propel market growth.
Some of the prominent players in the Skin Boosters Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Skin Boosters market.
By Type
By Gender
By End-use
By Region
Chapter 1 Methodology
1.1 Research Methodology
1.1.1 Information Procurement
1.2 Information Or Data Analysis
1.3 Market Formulation & Validation
1.4 Model Details
1.4.1 Commodity Flow Analysis (Model 1)
1.5 Region Wise Market Calculation
1.5.1 Region Wise Market: Base Estimates
1.5.2 Global Market: Cagr Calculation
1.6 List Of Secondary Sources
1.7 Estimates And Forecast Timeline
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Skin Boosters Market: Industry Outlook
3.1 Market Segmentation
3.2 Market Variable Analysis
3.2.1 Parent Market
3.2.2 Ancillary Market Outlook
3.3 Market Segmentation And Scope
3.4 Market Driver Analysis
3.5 Market Restraint Analysis
3.6 Penetration & Growth Prospect Mapping
3.7 Porter’s Five Forces Analysis
3.8 Pestel Analysis:
Chapter 5 Impact Of Covid-19
5.1 Impact Of Covid-19 On Esthetics Market
5.2 Impact Of Covid-19 On Skin Boosters Market
5.3 Dysmorphia Linked To Video Calling Is Likely To Drive Market Growth
5.4 Future Of Aesthetics
Chapter 6 Skin Boosters Market: Type Segment Analysis
6.1 Skin Boosters Market: Type Movement Analysis
6.2 Mesotherapy
6.2.1 Mesotherapy Market, 2020 - 2032
6.3 Microneedle
6.3.1 Microneedle Market, 2020 - 2032
Chapter 7 Skin Boosters Market: Gender Segment Analysis
7.1 Skin Boosters Market: Gender Movement Analysis
7.2 Female
7.2.1 Female End-Use Market, 2020 - 2032
7.3 Male
7.3.1 Male End-Use Market, 2020 - 2032
Chapter 8 Skin Boosters Market: End Use Segment Analysis
8.1 Skin Boosters Market: End-Use Movement Analysis
8.1.1 Med Spa
8.1.1.1 Medspa End-Use Market, 2020 - 2032
8.1.2 Dermatology Clinics
8.1.2.1 Dermatology Clinics End-Use Market, 2020 - 2032
Chapter 9 Skin Boosters Market: Regional Outlook
9.1 Skin Boosters Market Share By Region, 2023 & 2032
9.2 North America
9.2.1 North America Skin Boosters Market, 2020 - 2032
9.2.2 U.S.
9.2.2.1 U.S. Skin Boosters Market, 2020 - 2032
9.2.3 Canada
9.2.3.1 Canada Skin Boosters Market, 2020 - 2032
9.3 Europe
9.3.1 Europe Skin Boosters Market, 2020 - 2032
9.3.2 Uk
9.3.2.1 Uk Skin Boosters Market, 2020 - 2032
9.3.3 Germany
9.3.3.1 Germany Skin Boosters Market, 2020 - 2032
9.3.4 France
9.3.4.1 France Skin Boosters Market, 2020 - 2032
9.3.5 Italy
9.3.5.1 Italy Skin Boosters Market, 2020 - 2032
9.3.6 Spain
9.3.6.1 Spain Skin Boosters Market, 2020 - 2032
9.4 Asia Pacific
9.4.1 Asia Pacific Skin Boosters Market, 2020 - 2032
9.4.2 Japan
9.4.2.1 Japan Skin Boosters Market, 2020 - 2032
9.4.3 China
9.4.3.1 China Skin Boosters Market, 2020 - 2032
9.4.4 India
9.4.4.1 India Skin Boosters Market, 2020 - 2032
9.4.5 Australia
9.4.5.1 Australia Skin Boosters Market, 2020 - 2032
9.4.6 South Korea
9.4.6.1 South Korea Skin Boosters Market, 2020 - 2032
9.5 Latin America
9.5.1 Latin America Skin Boosters Market, 2020 - 2032
9.5.2 Brazil
9.5.2.1 Brazil Skin Boosters Market, 2020 - 2032
9.5.3 Mexico
9.5.3.1 Mexico Skin Boosters Market, 2020 - 2032
9.5.4 Argentina
9.5.3.1 Argentina Skin Boosters Market, 2020 - 2032
9.6 MEA
9.6.1 MEA Skin Boosters Market, 2020 - 2032
9.6.2 South Africa
9.6.2.1 South Africa Skin Boosters Market, 2020 - 2032
9.6.3 Saudi Arabia
9.6.3.1 Saudi Arabia Skin boosters market, 2020 - 2032
9.6.4 UAE
9.6.4.1 UAE Skin boosters market, 2020 - 2032
Chapter 10 Skin boosters Market - Competitive Analysis
10.1 Company Profiles
10.1.1 ALLERGAN
10.1.1.1 Company overview
10.1.1.2 Financial performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 GALDERMA.
10.1.2.1 Company overview
10.1.2.2 Financial performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic initiatives
10.1.3 MERZ AESTHETICS.
10.1.3.1 Company overview
10.1.3.2 Financial performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic initiatives
10.1.4 BLOOMAGE BIOTECHNOLOGY
10.1.4.1 Company overview
10.1.4.2 Financial performance
10.1.4.3 Product benchmarking
10.1.4.4 Strategic initiatives
10.1.5 TEOXANNE
10.1.5.1 Company overview
10.1.5.2 Financial performance
10.1.5.3 Product benchmarking
10.1.5.4 Strategic initiatives
10.1.6 FILORGA
10.1.6.1 Company overview
10.1.6.2 Strategic initiatives
10.1.6.3 Product benchmarking
10.1.6.4 Strategic Initiatives
10.1.7 PROFESSIONAL DERMA SA
10.1.7.1 Company overview
10.1.7.2 Product benchmarking
10.1.3.3 Financial Performance
10.1.3.4 Strategic initiatives
10.1.8 IBSA - INSTITUTEBIOCHEMICAL SA (IBSA DERMA)
10.1.8.1 Company overview
10.1.8.2 Product benchmarking
10.1.8.3 Financial performance
10.1.8.4 Strategic initiatives